Harvard scientists create first disease-specific human stem cell lines

Kevin Eggan, an assistant professor of stem-cell and regenerative biology, announced in Science that he had used the technique to create...

Two teams of researchers within the Harvard Stem Cell Institute (HSCI) announced in the last week that they have created disease-specific stem-cell lines using adult cells from human patients. The technique they used to achieve this, pioneered by Shinya Yamanaka of Kyoto University in 2006, employs viruses to reset adult cells to a primordial state. These induced pluripotent stem cells (iPS cells), as they are known, can then be prodded to differentiate into more specialized kinds of cells.

Kevin Eggan, an assistant professor of stem-cell and regenerative biology, announced in Science that he had used the technique to create motor neurons from the cells of an 82-year-old patient with ALS, or Lou Gehrig's disease. George Daley, an associate professor of biological chemistry and molecular pharmacology and of pediatrics, writing in Cell, announced that his laboratory had created 20 stem-cell lines representing a variety of afflictions, from "bubble-boy" disease to Parkinson's.

Douglas Melton, who co-directs the Harvard Stem Cell Institute, announced that HSCI would create a "core laboratory," dedicated to the iPS technique, that could be shared among the institute's researchers. He further announced that HSCI would distribute these new disease-bearing stem-cell lines, for a nominal fee, to researchers throughout the world.

The iPS cell lines created by Eggan and Daley will allow researchers to study the development of these diseases in a petri dish, making them phenomenally powerful tools for research. But the viruses and genes used in the Yamanaka iPS technique can cause cancer, so these cell lines cannot be used in human therapy.

Researchers worldwide emphasized that although the iPS technique might at first glance seem to obviate the need for working with embryonic stem cells derived from fertilized human eggs, those cells continue to remain important to the field of stem-cell research.

For background on stem-cell research at Harvard, see this magazine’s previous cover article “Stem-Cell Science.” Click here to read a copy of the Harvard press release about the discovery. Read more about Kevin Eggan’s work here.

Related topics

You might also like

Rachel Ruysch’s Lush (Still) Life

Now on display at the Museum of Fine Arts, a Dutch painter’s art proved a treasure trove for scientists.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

What Happens When Infections Stop Responding to Antibiotics?

Harvard Medical School experts discuss the growing threat of antimicrobial resistance.

Most popular

What Trump Means for John Roberts's Legacy

Executive power is on the docket at the Supreme Court.

The Harvard Professor Who Quantified Democracy

Erica Chenoweth’s data shows how—and when—authoritarians fall.

Harvard’s Endowment, Donations Rise—but the University Runs a Deficit

The annual financial report signals severe challenges to come.

Explore More From Current Issue

Three book covers arranged in a row on a beige background with a red border.

Must-Read Harvard Books Winter 2025

From aphorisms to art heists to democracy’s necessary conditions 

Six women interact in a theatrical setting, one seated and being comforted by others.

A (Truly) Naked Take on Second-Wave Feminism

Playwright Bess Wohl’s Liberation opens on Broadway.